Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models

Author(s): Cristina P.R. Xavier, Milica Pesic, M. Helena Vasconcelos

Journal Name: Current Cancer Drug Targets

Volume 16 , Issue 3 , 2016

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Despite the enormous number of anticancer drugs presently available in the clinic, treatment failure due to drug resistance is very frequent. The identification of mechanisms of resistance to different drugs is necessary, in order to identify ways to prevent and circumvent such resistance. Indeed, the identification of novel therapeutic targets to overcome cancer drug resistance remains one of the major challenges in drug discovery and development. The methods employed to identify drug resistance mechanisms and novel therapeutic targets depend greatly on the establishment of cancer drug resistant cell lines. The establishment of such drug resistant cell lines is laborious and time-consuming and various different approaches have been described. This manuscript reviews the methodologies that have been used to create cancer drug resistant cell lines and to identify their mechanisms of resistance. In addition, this review highlights the most frequent drug resistance mechanisms found in cancer cells.

Keywords: Acquired drug resistance, anticancer drugs, cancer drug resistance, drug resistant cancer cell lines, isogenic cell lines, mechanisms of drug resistance, multidrug resistance.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 13 November, 2015
Page: [226 - 237]
Pages: 12
DOI: 10.2174/1568009616666151113120705
Price: $65

Article Metrics

PDF: 167
HTML: 46
PRC: 1